Microbot Medical Inc. (MBOT)
USD 0.97
(-3.69%)
USD 0.97
(-3.69%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 9.85 Million USD | -99.93% |
| 2022 | 13.28 Million USD | 16.94% |
| 2021 | 11.35 Million USD | 24.95% |
| 2020 | 9.08 Million USD | 25.54% |
| 2019 | 7.24 Million USD | -0.06% |
| 2018 | 7.24 Million USD | 37.54% |
| 2017 | 5.26 Million USD | -45.33% |
| 2016 | 9.63 Million USD | -73.56% |
| 2015 | 36.44 Million USD | 14.17% |
| 2014 | 31.92 Million USD | 8.47% |
| 2013 | 29.43 Million USD | 26.34% |
| 2012 | 23.29 Million USD | -17.22% |
| 2011 | 28.14 Million USD | -7.42% |
| 2010 | 30.39 Million USD | 0.95% |
| 2009 | 30.1 Million USD | 15.35% |
| 2008 | 26.1 Million USD | -6.32% |
| 2007 | 27.86 Million USD | 29.82% |
| 2006 | 21.46 Million USD | 29.35% |
| 2005 | 16.59 Million USD | 6.78% |
| 2004 | 15.54 Million USD | 25.13% |
| 2003 | 12.41 Million USD | 16.89% |
| 2002 | 10.62 Million USD | -14.25% |
| 2001 | 12.39 Million USD | 2.21% |
| 2000 | 12.12 Million USD | -28.51% |
| 1999 | 16.95 Million USD | -32.44% |
| 1998 | 25.1 Million USD | 202.41% |
| 1997 | 8.3 Million USD | -66.26% |
| 1996 | 24.6 Million USD | 18.27% |
| 1995 | 20.8 Million USD | 4.0% |
| 1994 | 20 Million USD | 308.16% |
| 1993 | 4.9 Million USD | 32.43% |
| 1992 | 3.7 Million USD | 68.18% |
| 1991 | 2.2 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 2.49 Million USD | 6.58% |
| 2024 Q1 | 2.35 Million USD | 15.89% |
| 2023 Q1 | 2.91 Million USD | -4.86% |
| 2023 FY | 9.74 Million USD | -26.59% |
| 2023 Q4 | 2.03 Million USD | -20.09% |
| 2023 Q2 | 2.32 Million USD | -20.38% |
| 2023 Q3 | 2.54 Million USD | 9.47% |
| 2022 FY | 13.28 Million USD | 16.94% |
| 2022 Q4 | 3.06 Million USD | -11.69% |
| 2022 Q3 | 3.47 Million USD | -2.5% |
| 2022 Q2 | 3.56 Million USD | 12.19% |
| 2022 Q1 | 3.17 Million USD | -19.33% |
| 2021 FY | 11.35 Million USD | 24.95% |
| 2021 Q1 | 2.39 Million USD | -8.95% |
| 2021 Q2 | 2.47 Million USD | 3.51% |
| 2021 Q3 | 2.55 Million USD | 3.07% |
| 2021 Q4 | 3.93 Million USD | 54.27% |
| 2020 Q1 | 2.16 Million USD | 8.8% |
| 2020 FY | 9.08 Million USD | 25.54% |
| 2020 Q4 | 2.62 Million USD | 8.78% |
| 2020 Q3 | 2.41 Million USD | 28.18% |
| 2020 Q2 | 1.88 Million USD | -12.9% |
| 2019 Q1 | 1.91 Million USD | -8.06% |
| 2019 Q3 | 1.79 Million USD | 15.92% |
| 2019 FY | 7.24 Million USD | -0.06% |
| 2019 Q4 | 1.98 Million USD | 11.0% |
| 2019 Q2 | 1.54 Million USD | -19.36% |
| 2018 Q2 | 1.89 Million USD | 24.88% |
| 2018 FY | 7.24 Million USD | 37.54% |
| 2018 Q1 | 1.51 Million USD | -1.43% |
| 2018 Q4 | 2.08 Million USD | 18.88% |
| 2018 Q3 | 1.75 Million USD | -7.35% |
| 2017 FY | 5.26 Million USD | -45.33% |
| 2017 Q1 | 1.23 Million USD | 117.07% |
| 2017 Q2 | 1.26 Million USD | 2.35% |
| 2017 Q3 | 1.23 Million USD | -2.14% |
| 2017 Q4 | 1.53 Million USD | 24.45% |
| 2016 Q2 | 5.1 Million USD | -48.06% |
| 2016 Q1 | 9.83 Million USD | 20.91% |
| 2016 FY | 9.63 Million USD | -73.56% |
| 2016 Q4 | -7.22 Million USD | -478.12% |
| 2016 Q3 | 1.9 Million USD | -62.62% |
| 2015 FY | 36.44 Million USD | 14.17% |
| 2015 Q2 | 9.3 Million USD | 3.58% |
| 2015 Q1 | 8.98 Million USD | -15.37% |
| 2015 Q3 | 10.02 Million USD | 7.76% |
| 2015 Q4 | 8.13 Million USD | -18.84% |
| 2014 Q4 | 10.61 Million USD | 57.73% |
| 2014 Q1 | 7.15 Million USD | -26.25% |
| 2014 Q3 | 6.72 Million USD | -18.63% |
| 2014 Q2 | 8.26 Million USD | 15.61% |
| 2014 FY | 31.92 Million USD | 8.47% |
| 2013 FY | 29.43 Million USD | 26.34% |
| 2013 Q2 | 6.38 Million USD | -1.01% |
| 2013 Q4 | 9.69 Million USD | 40.64% |
| 2013 Q3 | 6.89 Million USD | 7.97% |
| 2013 Q1 | 6.45 Million USD | -5.02% |
| 2012 Q2 | 5.52 Million USD | -5.76% |
| 2012 FY | 23.29 Million USD | -17.22% |
| 2012 Q4 | 6.79 Million USD | 32.8% |
| 2012 Q1 | 5.86 Million USD | -17.71% |
| 2012 Q3 | 5.11 Million USD | -7.43% |
| 2011 FY | 28.14 Million USD | -7.42% |
| 2011 Q1 | 7.6 Million USD | -9.62% |
| 2011 Q2 | 7.15 Million USD | -5.84% |
| 2011 Q3 | 6.25 Million USD | -12.58% |
| 2011 Q4 | 7.12 Million USD | 13.86% |
| 2010 Q2 | 7.14 Million USD | -6.26% |
| 2010 Q3 | 7.21 Million USD | 1.03% |
| 2010 Q1 | 7.62 Million USD | -15.1% |
| 2010 Q4 | 8.41 Million USD | 16.51% |
| 2010 FY | 30.39 Million USD | 0.95% |
| 2009 Q3 | 7.1 Million USD | -2.15% |
| 2009 FY | 30.1 Million USD | 15.35% |
| 2009 Q1 | 6.77 Million USD | 5.79% |
| 2009 Q4 | 8.97 Million USD | 26.44% |
| 2009 Q2 | 7.25 Million USD | 7.11% |
| 2008 Q4 | 6.4 Million USD | 9.33% |
| 2008 Q3 | 5.85 Million USD | -15.47% |
| 2008 Q2 | 6.92 Million USD | 0.21% |
| 2008 Q1 | 6.91 Million USD | -8.66% |
| 2008 FY | 26.1 Million USD | -6.32% |
| 2007 Q2 | 5.9 Million USD | -9.2% |
| 2007 Q1 | 6.5 Million USD | -1.17% |
| 2007 Q3 | 7.74 Million USD | 31.18% |
| 2007 Q4 | 7.56 Million USD | -2.31% |
| 2007 FY | 27.86 Million USD | 29.82% |
| 2006 FY | 21.46 Million USD | 29.35% |
| 2006 Q1 | 4.52 Million USD | -2.57% |
| 2006 Q4 | 6.58 Million USD | 17.95% |
| 2006 Q3 | 5.58 Million USD | 213.69% |
| 2006 Q2 | -4.9 Million USD | -208.47% |
| 2005 FY | 16.59 Million USD | 6.78% |
| 2005 Q4 | 4.64 Million USD | 11.04% |
| 2005 Q3 | 4.18 Million USD | 1.51% |
| 2005 Q2 | 4.12 Million USD | 13.05% |
| 2005 Q1 | 3.64 Million USD | -28.1% |
| 2004 FY | 15.54 Million USD | 25.13% |
| 2004 Q2 | 3.28 Million USD | 14.74% |
| 2004 Q3 | 4.32 Million USD | 31.68% |
| 2004 Q4 | 5.06 Million USD | 17.23% |
| 2004 Q1 | 2.86 Million USD | -40.58% |
| 2003 Q1 | 2.4 Million USD | 32.49% |
| 2003 Q4 | 4.81 Million USD | 96.51% |
| 2003 Q3 | 2.45 Million USD | -10.63% |
| 2003 FY | 12.41 Million USD | 16.89% |
| 2003 Q2 | 2.74 Million USD | 13.86% |
| 2002 Q2 | 3.16 Million USD | 10.07% |
| 2002 Q4 | 1.81 Million USD | -34.24% |
| 2002 Q1 | 2.87 Million USD | -21.67% |
| 2002 FY | 10.62 Million USD | -14.25% |
| 2002 Q3 | 2.76 Million USD | -12.67% |
| 2001 Q1 | 2.78 Million USD | -51.92% |
| 2001 Q4 | 3.67 Million USD | 73.32% |
| 2001 FY | 12.39 Million USD | 2.21% |
| 2001 Q3 | 2.11 Million USD | -46.49% |
| 2001 Q2 | 3.95 Million USD | 42.24% |
| 2000 Q2 | 2.09 Million USD | 2.54% |
| 2000 Q3 | 2.18 Million USD | 4.26% |
| 2000 Q4 | 5.78 Million USD | 164.57% |
| 2000 FY | 12.12 Million USD | -28.51% |
| 2000 Q1 | 2.04 Million USD | 697.64% |
| 1999 Q3 | 7.3 Million USD | 43.14% |
| 1999 FY | 16.95 Million USD | -32.44% |
| 1999 Q1 | 5.2 Million USD | -14.75% |
| 1999 Q2 | 5.1 Million USD | -1.92% |
| 1999 Q4 | -342.5 Thousand USD | -104.69% |
| 1998 FY | 25.1 Million USD | 202.41% |
| 1998 Q4 | 6.1 Million USD | -1.61% |
| 1998 Q3 | 6.2 Million USD | -7.46% |
| 1998 Q2 | 6.7 Million USD | 9.84% |
| 1998 Q1 | 6.1 Million USD | 130.35% |
| 1997 FY | 8.3 Million USD | -66.26% |
| 1997 Q4 | -20.1 Million USD | -235.81% |
| 1997 Q3 | 14.8 Million USD | 124.24% |
| 1997 Q2 | 6.6 Million USD | -5.71% |
| 1997 Q1 | 7 Million USD | -1.41% |
| 1996 FY | 24.6 Million USD | 18.27% |
| 1996 Q3 | 6.2 Million USD | 6.9% |
| 1996 Q2 | 5.8 Million USD | 5.45% |
| 1996 Q1 | 5.5 Million USD | -3.51% |
| 1996 Q4 | 7.1 Million USD | 14.52% |
| 1995 Q2 | 1.5 Million USD | -69.39% |
| 1995 FY | 20.8 Million USD | 4.0% |
| 1995 Q1 | 4.9 Million USD | -3.92% |
| 1995 Q4 | 5.7 Million USD | 14.0% |
| 1995 Q3 | 5 Million USD | 233.33% |
| 1994 Q2 | 5 Million USD | 11.11% |
| 1994 FY | 20 Million USD | 308.16% |
| 1994 Q1 | 4.5 Million USD | 129.61% |
| 1994 Q4 | 5.1 Million USD | -1.92% |
| 1994 Q3 | 5.2 Million USD | 4.0% |
| 1993 Q2 | 1.6 Million USD | 23.08% |
| 1993 Q3 | - USD | -100.0% |
| 1993 Q4 | -15.2 Million USD | 0.0% |
| 1993 FY | 4.9 Million USD | 32.43% |
| 1993 Q1 | 1.3 Million USD | 111.71% |
| 1992 Q1 | - USD | 100.0% |
| 1992 FY | 3.7 Million USD | 68.18% |
| 1992 Q3 | - USD | 0.0% |
| 1992 Q2 | - USD | 0.0% |
| 1992 Q4 | -11.1 Million USD | 0.0% |
| 1991 FY | 2.2 Million USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| 1991 Q1 | - USD | 0.0% |
| 1991 Q4 | -6.9 Million USD | 0.0% |
| 1991 Q3 | - USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 104.27 Million USD | 90.549% |
| AngioDynamics, Inc. | 252.41 Million USD | 96.096% |
| AtriCure, Inc. | 327.05 Million USD | 96.987% |
| Avinger, Inc. | 18.63 Million USD | 47.124% |
| Azenta, Inc. | 336.26 Million USD | 97.069% |
| BioLife Solutions, Inc. | 117.57 Million USD | 91.618% |
| The Cooper Companies, Inc. | 1.82 Billion USD | 99.46% |
| Daxor Corporation | 1.28 Million USD | -669.612% |
| Ekso Bionics Holdings, Inc. | 24.19 Million USD | 59.262% |
| Femasys Inc. | 15.2 Million USD | 35.166% |
| GlucoTrack, Inc. | 7.1 Million USD | -38.725% |
| Harvard Bioscience, Inc. | 58.58 Million USD | 83.177% |
| Hologic, Inc. | 1.34 Billion USD | 99.267% |
| ICU Medical, Inc. | 717.04 Million USD | 98.626% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | 99.667% |
| KORU Medical Systems, Inc. | 26.1 Million USD | 62.253% |
| LeMaitre Vascular, Inc. | 90.33 Million USD | 89.091% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 8358.68% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 8358.68% |
| Masimo Corporation | 867 Million USD | 98.863% |
| Meihua International Medical Technologies Co., Ltd. | 18.42 Million USD | 46.499% |
| Merit Medical Systems, Inc. | 459.92 Million USD | 97.857% |
| Nephros, Inc. | 9.78 Million USD | -0.726% |
| NovoCure Limited | 613.92 Million USD | 98.395% |
| NEXGEL, Inc. | 4.09 Million USD | -140.601% |
| NEXGEL, Inc. | 4.09 Million USD | -140.601% |
| Singular Genomics Systems, Inc. | 102.24 Million USD | 90.361% |
| OraSure Technologies, Inc. | 125.34 Million USD | 92.138% |
| Pro-Dex, Inc. | 7.37 Million USD | -33.573% |
| Pulse Biosciences, Inc. | 43.57 Million USD | 77.383% |
| Predictive Oncology Inc. | 15.22 Million USD | 35.29% |
| Precision Optics Corporation, Inc. | 8.52 Million USD | -15.64% |
| QuidelOrtho Corporation | 1.35 Billion USD | 99.273% |
| Repligen Corporation | 261.12 Million USD | 96.226% |
| Sanara MedTech Inc. | 61.12 Million USD | 83.878% |
| STAAR Surgical Company | 224.55 Million USD | 95.611% |
| Sharps Technology, Inc. | 10.12 Million USD | 2.683% |
| Utah Medical Products, Inc. | 13.26 Million USD | 25.684% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | 99.451% |
| Jin Medical International Ltd. | 3.91 Million USD | -151.559% |